292 related articles for article (PubMed ID: 31508377)
1. Chemoresistance Mediated by ceRNA Networks Associated With the PVT1 Locus.
Ogunwobi OO; Kumar A
Front Oncol; 2019; 9():834. PubMed ID: 31508377
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA PVT1: A promising chemotherapy and radiotherapy sensitizer.
Yao W; Li S; Liu R; Jiang M; Gao L; Lu Y; Liang X; Zhang H
Front Oncol; 2022; 12():959208. PubMed ID: 35965522
[TBL] [Abstract][Full Text] [Related]
3. Role of the long non-coding RNA PVT1 in the dysregulation of the ceRNA-ceRNA network in human breast cancer.
Conte F; Fiscon G; Chiara M; Colombo T; Farina L; Paci P
PLoS One; 2017; 12(2):e0171661. PubMed ID: 28187158
[TBL] [Abstract][Full Text] [Related]
4.
Martínez-Barriocanal Á; Arango D; Dopeso H
Front Oncol; 2020; 10():38. PubMed ID: 32083000
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic Associations between lncRNA/circRNA and miRNA in Hepatocellular Carcinoma.
Han TS; Hur K; Cho HS; Ban HS
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32937886
[TBL] [Abstract][Full Text] [Related]
6. Long Noncoding Competing Endogenous RNA Networks in Pancreatic Cancer.
Xiong G; Pan S; Jin J; Wang X; He R; Peng F; Li X; Wang M; Zheng J; Zhu F; Qin R
Front Oncol; 2021; 11():765216. PubMed ID: 34760707
[TBL] [Abstract][Full Text] [Related]
7. Regulation mechanism and pathogenic role of lncRNA plasmacytoma variant translocation 1 (
Wu F; Zhu Y; Zhou C; Gui W; Li H; Lin X
Genes Dis; 2023 May; 10(3):901-914. PubMed ID: 37396533
[TBL] [Abstract][Full Text] [Related]
8. Emerging role of competing endogenous RNA and associated noncoding RNAs in thyroid cancer.
Bai Q; Pan Z; Nabi G; Rashid F; Liu Y; Khan S
Am J Cancer Res; 2022; 12(3):961-973. PubMed ID: 35411240
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA GSTM3TV2 upregulates LAT2 and OLR1 by competitively sponging let-7 to promote gemcitabine resistance in pancreatic cancer.
Xiong G; Liu C; Yang G; Feng M; Xu J; Zhao F; You L; Zhou L; Zheng L; Hu Y; Wang X; Zhang T; Zhao Y
J Hematol Oncol; 2019 Sep; 12(1):97. PubMed ID: 31514732
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA PVT1-5 promotes cell proliferation by regulating miR-126/SLC7A5 axis in lung cancer.
Li H; Chen S; Liu J; Guo X; Xiang X; Dong T; Ran P; Li Q; Zhu B; Zhang X; Wang D; Xiao C; Zheng S
Biochem Biophys Res Commun; 2018 Jan; 495(3):2350-2355. PubMed ID: 29277611
[TBL] [Abstract][Full Text] [Related]
11. Competitive endogenous network of lncRNA, miRNA, and mRNA in the chemoresistance of gastrointestinal tract adenocarcinomas.
Raziq K; Cai M; Dong K; Wang P; Afrifa J; Fu S
Biomed Pharmacother; 2020 Oct; 130():110570. PubMed ID: 32763816
[TBL] [Abstract][Full Text] [Related]
12. PVT1 lncRNA in lung cancer: A key player in tumorigenesis and therapeutic opportunities.
Hakami MA; Hazazi A; Khan FR; Abdulaziz O; Alshaghdali K; Abalkhail A; Nassar SA; Omar BIA; Almarshadi F; Gupta G; Binshaya AS
Pathol Res Pract; 2024 Jan; 253():155019. PubMed ID: 38091883
[TBL] [Abstract][Full Text] [Related]
13. The ceRNA network regulates epithelial-mesenchymal transition in colorectal cancer.
Li R; Xu H; Gao X
Heliyon; 2023 Mar; 9(3):e14143. PubMed ID: 36950593
[TBL] [Abstract][Full Text] [Related]
14. Progress of circRNA/lncRNA-miRNA-mRNA axis in atrial fibrillation.
Wen JL; Ruan ZB; Wang F; Hu Y
PeerJ; 2023; 11():e16604. PubMed ID: 38144204
[TBL] [Abstract][Full Text] [Related]
15. LINC02418 upregulates EPHA2 by competitively sponging miR-372-3p to promote 5-Fu/DDP chemoresistance in colorectal cancer.
Yao F; Huang X; Xie Z; Chen J; Zhang L; Wang Q; Long H; Jiang J; Wu Q
Carcinogenesis; 2022 Oct; 43(9):895-907. PubMed ID: 35914269
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of long noncoding RNA PVT1 suppresses cell proliferation and invasion of colorectal cancer via upregulation of microRNA-214-3p.
Shang AQ; Wang WW; Yang YB; Gu CZ; Ji P; Chen C; Zeng BJ; Wu JL; Lu WY; Sun ZJ; Li D
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G222-G232. PubMed ID: 31125260
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of thyroid cancer: A competing endogenous RNA (ceRNA) point of view.
Liu Y; Khan S; Li L; Ten Hagen TLM; Falahati M
Biomed Pharmacother; 2022 Feb; 146():112251. PubMed ID: 34916087
[TBL] [Abstract][Full Text] [Related]
18. Competitive endogenous network of circRNA, lncRNA, and miRNA in osteosarcoma chemoresistance.
Qin S; Wang Y; Ma C; Lv Q
Eur J Med Res; 2023 Sep; 28(1):354. PubMed ID: 37717007
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of an lncRNA-miRNA-mRNA competing endogenous RNA network in pulpitis.
Lei F; Zhang H; Xie X
PeerJ; 2019; 7():e7135. PubMed ID: 31304055
[TBL] [Abstract][Full Text] [Related]
20. PVT1 Signaling Is a Mediator of Cancer Progression.
Derderian C; Orunmuyi AT; Olapade-Olaopa EO; Ogunwobi OO
Front Oncol; 2019; 9():502. PubMed ID: 31249809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
